In the early 1980s, Le Bonheur Children’s Medical Center in Memphis formed several healthcare companies to distribute clotting factor and Protropin throughout the Southeast. These product lines were eventually consolidated into a company called Accredo Nova Factor, Inc. (ANF).

In 1996, Accredo Health, Inc., was founded by a venture capital firm to acquire ANF. By the following year, ANF had reached $100 million in annual sales. Seeking additional growth within the specialty market, Accredo Health, Inc., acquired Hemophilia Health Services, Inc. (HHS), which had originally been started by a mother in response to her son’s hemophilia.

Accredo became a publicly traded company in 1999. That same year, HHS acquired Sunrise Health Management and entered the IVIG market. Other acquisitions soon followed, including Pharmacare Resources, Inc., and BioPartners in Care, Inc., as well as the Specialty Pharmaceutical Services and Clinical Business Solutions divisions of Gentiva Health Services, Inc. One of those former Gentiva companies was renamed to create a new division, Accredo Therapeutics, Inc. (ATX) to focus on immunoglobulin and PAH therapies.

During this period, Accredo Health, Inc., continually expanded its role in the specialty pharmacy industry, and it was soon dispensing an elite array of biopharmaceuticals: Ceredase, Cerezyme, Avonex, Synagis, Tracleer, Orfadin, Actimmune, Adagen, Enbrel, Flolan, Remodulin, Xolair, Raptiva, Aldurazyme, Fabrazyme, Aralast,Zemaira, and Apokyn. In 2003, ATX was awarded accreditation by the Joint Commission on the Accreditation of Healthcare Organizations (JCAHO). That year, Accredo acquired Alpha Therapeutics Services. Home HealthCare Resources, Inc., Hemophilia Resources of America, Inc., and the pharmacy division of Pediatric Services of America, Inc., soon became part of our company.

ATX is now part of Accredo Health Group (AHG). In January 2006, Hemophilia Health Services also became divisions of Accredo to make it easier for the managed care community to recognize our name and to access all our services.

In 2004, Medco Health Solutions, Inc. (newly independent from Merck) and Accredo Health, Inc., announced a strategic alliance for specialty pharmacy. Accredo Health, Inc., became a wholly owned subsidiary of Medco the following year.